Trial Report Randomized, waitlist-controlled trial of Cordyceps sinensis mycelium culture extract (Cs4) for long COVID patients in Hong Kong, 2025, Chen et al

Discussion in 'Long Covid research' started by forestglip, Feb 28, 2025.

  1. forestglip

    forestglip Senior Member (Voting Rights)

    Messages:
    1,778
    Randomized, waitlist-controlled trial of Cordyceps sinensis mycelium culture extract (Cs4) for long COVID patients in Hong Kong

    Yuanyuan Chen, Guang Chen, Cheng Zhang, Guoyi Tang, Yautuen Chan, Ning Wang, Yibin Feng

    [Line breaks added]


    Abstract
    We assessed Cordyceps sinensis mycelium culture extract (Cs4) for alleviating long COVID symptoms. In this randomized trial 110 participants were assigned to receive Cs4 (55 participants) or were waitlisted (55 participants) for 12 weeks.

    The primary outcome was the change in long COVID symptom severity at 12 weeks, as measured by the modified COVID-19 Yorkshire Rehabilitation Scale. The secondary outcomes included changes in the Brief Fatigue Inventory Form, Insomnia Severity Index, Hospital Anxiety and Depression Scale, St. George’s Respiratory Questionnaire, and the Short Form 12 health survey at 12 weeks.

    Participants receiving Cs4 showed improvement in long COVID symptoms compared to the waitlist control group (MD, −10.1; 95% CI, −14.1 to −6.1; P < 0.001) at 12 weeks. Cs4 recipients also experienced improvement in fatigue (MD, −8.1; 95% CI, −14.2 to −2.0; P = 0.011), insomnia (MD, −2.9; 95% CI, −4.6 to −1.2; P = 0.001), and respiratory symptoms (MD, −6.3; 95% CI, −11.4 to −1.2; P = 0.018). Cs4 also improved the quality of life (physical component MD, 7.0; 95% CI, 4.2–9.8; P < 0.001; mental component MD, 6.8; 95% CI, 2.9–10.7; P < 0.001).

    No severe adverse events were reported. Cs4 may be a beneficial treatment for patients with long COVID symptoms.

    Link | PDF (Acta Materia Medica) [Open Access]
     
    Hutan and Peter Trewhitt like this.
  2. Jaybee00

    Jaybee00 Senior Member (Voting Rights)

    Messages:
    2,321
    Cs4 placebo could not be blinded due the unique color and smell, therefore the waitlist control group received Cs4 after the first waiting period
     
    Hutan and Peter Trewhitt like this.
  3. Jaybee00

    Jaybee00 Senior Member (Voting Rights)

    Messages:
    2,321
    Last edited: Feb 28, 2025
    Peter Trewhitt likes this.
  4. Utsikt

    Utsikt Senior Member (Voting Rights)

    Messages:
    1,155
    Location:
    Norway
    Why not use solid coloured capsules?
     
    Dolphin, Hutan and Peter Trewhitt like this.
  5. Mij

    Mij Senior Member (Voting Rights)

    Messages:
    10,073
    Why not eat the real thing? My Asian friends boil this in a ceramic pot with a lid slowed cooked for 2 hrs.
     
    Peter Trewhitt likes this.
  6. Hutan

    Hutan Moderator Staff Member

    Messages:
    31,363
    Location:
    Aotearoa New Zealand
    The authors' take on existing treatment guidance for Long Covid (and ME/CFS):
    Was there going to be a good trial of low dose naltrexone? I'm tired of it being touted as being useful in ME/CFS when there is no good evidence for that.
     
    Peter Trewhitt likes this.
  7. Hutan

    Hutan Moderator Staff Member

    Messages:
    31,363
    Location:
    Aotearoa New Zealand
    Yes, making this study pretty much useless, unless the improvements were really large.

    With the bias probably made worse by selective recruitment and what seems to have been a campaign to hype Cs4 just prior to the trial.
     
    Peter Trewhitt likes this.
  8. Hutan

    Hutan Moderator Staff Member

    Messages:
    31,363
    Location:
    Aotearoa New Zealand
    Measures, with the score ranges
     
    Peter Trewhitt likes this.

Share This Page